Prognostic value of high-sensitivity cardiac troponin I after isolated non-CABG cardiac surgery
Felix Rudolph1,2, Marcus-André Deutsch3, Kai Peter Friedrichs4
1Department of General and Interventional Cardiology/Angiology, Heart and Diabetes Center NRW, Ruhr University Bochum, Medical Faculty OWL (University of Bielefeld), Bad Oeynhausen, Germany.
Insights
Peak postoperative high-sensitivity cardiac troponin I (hs-cTnI) levels predict mortality after heart valve or thoracic aortic surgery. However, their poor predictive performance indicates a need for surgery-specific thresholds for better risk assessment.
Area of Science:
- Cardiovascular Surgery
- Cardiac Biomarkers
- Prognostic Indicators
Background:
- High-sensitivity cardiac troponin I (hs-cTnI) is a key biomarker in acute coronary syndromes.
- Its prognostic role in patients undergoing cardiac valvular (CV) or thoracic aortic (TA) surgery without coronary artery bypass grafting (CABG) remains to be fully elucidated.
Purpose of the Study:
- To investigate the prognostic value of peak postoperative hs-cTnI levels.
- To assess the association between hs-cTnI and short-term (30-day) and long-term all-cause mortality in patients undergoing isolated CV or TA surgery.
Main Methods:
- Prospective, single-center registry analysis of 4232 adult patients undergoing elective, isolated CV or TA surgery.
- Hs-cTnI levels measured preoperatively and up to 48 hours postoperatively.
- Cox proportional hazards models with regression splines used to assess associations with mortality, adjusted for EuroSCORE II.
Main Results:
- Peak hs-cTnI thresholds of 282×ULN and 194×ULN were associated with increased long-term and 30-day mortality risk, respectively.
- Predictive performance was limited, with Area Under the Curve (AUC) values of 0.56 for long-term and 0.55 for 30-day mortality.
- Sex-specific thresholds showed slightly improved AUCs (0.58 and 0.57, respectively), but overall discrimination remained poor.
Conclusions:
- Peak hs-cTnI levels are independently associated with adverse outcomes after CV or TA surgery without CABG.
- Current hs-cTnI thresholds offer poor risk discrimination in this patient population.
- Development of surgery-specific hs-cTnI thresholds is necessary for improved perioperative risk stratification.
Objective:
To evaluate the prognostic value of peak postoperative high-sensitivity cardiac troponin I (hs-cTnI) in patients undergoing cardiac valvular (CV) or thoracic aortic (TA) surgery without concomitant coronary artery bypass grafting (CABG).
Methods:
We analyzed data from a prospective, single-center registry of adult patients (≥ 18 years) who underwent elective, isolated CV or TA surgery at a tertiary hospital in Germany between January 2013 and May 2019. Hs-cTnI levels were measured preoperatively and postoperatively at regular intervals up to 48 h. The associations between peak hs-cTnI and long-term and 30-day all-cause mortality were assessed using Cox proportional hazards models with regression splines, adjusted for baseline risk via EuroSCORE II.
Results:
Among 4232 patients (median age 69 years [IQR 59-76]; 38.4% female), 30-day all-cause mortality occurred in 61 patients (1.4%). Over a median follow-up of 3.1 years [IQR 1.9-5.0], 499 patients (11.8%) died. Peak hs-cTnI thresholds of 282 × the upper limit of normal (ULN) and 194 × ULN were associated with increased risk of long-term (HR 1.11, 95% CI 1.00-1.24) and 30-day mortality (hazard ratio (HR) 1.25, 95% CI 1.01-1.55), respectively. However, predictive performance was limited with area under the receiver operating curve (AUC) values of 0.56 for long-term mortality and 0.55 for 30-day mortality. Sensitivity and specificity were 41% and 71% for long-term mortality, and 54% and 55% for 30-day all-cause mortality. Negative predictive values remained high (both at 90%), but negative predictive values were low at 16% and 14%, respectively. When applying the sex-specific reference levels (16 pg/ml for women, 34 pg/ml for men), thresholds of 223 × ULN and 194 × ULN were identified for long-term and 30-day mortality, with corresponding HRs of 1.08 and 1.62 and AUCs of 0.58 and 0.57, respectively.
Conclusion:
Peak hs-cTnI levels are independently associated with adverse outcomes following CV or TA surgery without CABG. However, effective risk discrimination is poor, and the identified thresholds far exceed conventional definitions of myocardial infarction. These findings support the need for surgery-specific hs-cTnI thresholds to improve perioperative risk stratification.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome IV: Interprofessional Care
Cardiac Catheterization IV: Nursing Management
